432 related articles for article (PubMed ID: 22728850)
21. Systematic genetic study of Alzheimer disease in Latin America: mutation frequencies of the amyloid beta precursor protein and presenilin genes in Colombia.
Arango D; Cruts M; Torres O; Backhovens H; Serrano ML; Villareal E; Montañes P; Matallana D; Cano C; Van Broeckhoven C; Jacquier M
Am J Med Genet; 2001 Oct; 103(2):138-43. PubMed ID: 11568920
[TBL] [Abstract][Full Text] [Related]
22. Mutations in presenilin 1, presenilin 2 and amyloid precursor protein genes in patients with early-onset Alzheimer's disease in Poland.
Zekanowski C; Styczyńska M; Pepłońska B; Gabryelewicz T; Religa D; Ilkowski J; Kijanowska-Haładyna B; Kotapka-Minc S; Mikkelsen S; Pfeffer A; Barczak A; Łuczywek E; Wasiak B; Chodakowska-Zebrowska M; Gustaw K; Łaczkowski J; Sobów T; Kuźnicki J; Barcikowska M
Exp Neurol; 2003 Dec; 184(2):991-6. PubMed ID: 14769392
[TBL] [Abstract][Full Text] [Related]
23. Exploring the etiology of Alzheimer disease using molecular genetics.
Lendon CL; Ashall F; Goate AM
JAMA; 1997 Mar; 277(10):825-31. PubMed ID: 9052714
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of pathogenic mutations in an Italian clinical series of patients with familial dementia.
Signorini S; Ghidoni R; Barbiero L; Benussi L; Binetti G
Curr Alzheimer Res; 2004 Aug; 1(3):215-8. PubMed ID: 15975068
[TBL] [Abstract][Full Text] [Related]
25. Brain expression of presenilins in sporadic and early-onset, familial Alzheimer's disease.
Mathews PM; Cataldo AM; Kao BH; Rudnicki AG; Qin X; Yang JL; Jiang Y; Picciano M; Hulette C; Lippa CF; Bird TD; Nochlin D; Walter J; Haass C; Lévesque L; Fraser PE; Andreadis A; Nixon RA
Mol Med; 2000 Oct; 6(10):878-91. PubMed ID: 11126202
[TBL] [Abstract][Full Text] [Related]
26. Epileptic seizures in autosomal dominant forms of Alzheimer's disease.
Cortini F; Cantoni C; Villa C
Seizure; 2018 Oct; 61():4-7. PubMed ID: 30041064
[TBL] [Abstract][Full Text] [Related]
27. Effects of gene mutation and disease progression on representative neural circuits in familial Alzheimer's disease.
Quan M; Zhao T; Tang Y; Luo P; Wang W; Qin Q; Li T; Wang Q; Fang J; Jia J
Alzheimers Res Ther; 2020 Jan; 12(1):14. PubMed ID: 31937364
[TBL] [Abstract][Full Text] [Related]
28. Formation of stable complexes between two Alzheimer's disease gene products: presenilin-2 and beta-amyloid precursor protein.
Weidemann A; Paliga K; Dürrwang U; Czech C; Evin G; Masters CL; Beyreuther K
Nat Med; 1997 Mar; 3(3):328-32. PubMed ID: 9055862
[TBL] [Abstract][Full Text] [Related]
29. Familial Alzheimer's disease: site of mutation influences clinical phenotype.
Lippa CF; Swearer JM; Kane KJ; Nochlin D; Bird TD; Ghetti B; Nee LE; St George-Hyslop P; Pollen DA; Drachman DA
Ann Neurol; 2000 Sep; 48(3):376-9. PubMed ID: 10976645
[TBL] [Abstract][Full Text] [Related]
30. Presenilin function in APP processing.
Annaert W; Cupers P; Saftig P; De Strooper B
Ann N Y Acad Sci; 2000; 920():158-64. PubMed ID: 11193144
[TBL] [Abstract][Full Text] [Related]
31. [The AAP and PS1/2 mutations linked to early onset familial Alzheimer's disease increase the extracellular concentration and A beta 1-42 (43)].
Younkin SG
Rinsho Shinkeigaku; 1997 Dec; 37(12):1099. PubMed ID: 9577655
[No Abstract] [Full Text] [Related]
32. Identification of new presenilin gene mutations in early-onset familial Alzheimer disease.
Tedde A; Nacmias B; Ciantelli M; Forleo P; Cellini E; Bagnoli S; Piccini C; Caffarra P; Ghidoni E; Paganini M; Bracco L; Sorbi S
Arch Neurol; 2003 Nov; 60(11):1541-4. PubMed ID: 14623725
[TBL] [Abstract][Full Text] [Related]
33. Monogenic determinants of familial Alzheimer's disease: presenilin-2 mutations.
Renbaum P; Levy-Lahad E
Cell Mol Life Sci; 1998 Sep; 54(9):910-9. PubMed ID: 9791533
[TBL] [Abstract][Full Text] [Related]
34. [Advances in molecular biology and clinical study of amyloid precursor protein for Alzheimer's disease].
Xu BG; Wu X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):201-9. PubMed ID: 15171563
[TBL] [Abstract][Full Text] [Related]
35. The impact of different presenilin 1 andpresenilin 2 mutations on amyloid deposition, neurofibrillary changes and neuronal loss in the familial Alzheimer's disease brain: evidence for other phenotype-modifying factors.
Gómez-Isla T; Growdon WB; McNamara MJ; Nochlin D; Bird TD; Arango JC; Lopera F; Kosik KS; Lantos PL; Cairns NJ; Hyman BT
Brain; 1999 Sep; 122 ( Pt 9)():1709-19. PubMed ID: 10468510
[TBL] [Abstract][Full Text] [Related]
36. [Familial forms of Alzheimer's disease].
Maréchal L; Campion D; Hannequin D
Presse Med; 2003 May; 32(16):756-63. PubMed ID: 12856536
[TBL] [Abstract][Full Text] [Related]
37. Genetic complexity of Alzheimer's disease: successes and challenges.
Rogaeva E; Kawarai T; George-Hyslop PS
J Alzheimers Dis; 2006; 9(3 Suppl):381-7. PubMed ID: 16914876
[TBL] [Abstract][Full Text] [Related]
38. [Genetic factors and a polygenic model of Alzheimer's disease].
Rogaev EI
Genetika; 1999 Nov; 35(11):1558-71. PubMed ID: 10624576
[TBL] [Abstract][Full Text] [Related]
39. Presenile because of presenilin: the presenilin genes and early onset Alzheimer's disease.
Haass C
Curr Opin Neurol; 1996 Aug; 9(4):254-9. PubMed ID: 8858181
[TBL] [Abstract][Full Text] [Related]
40. [Molecular cell biology of presenilins].
Tomita T; Iwatsubo T
Nihon Yakurigaku Zasshi; 1999 Dec; 114(6):337-46. PubMed ID: 10672594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]